- Home
- FNGR vs FBRX Comparison
FNGR vs FBRX Comparison
Compare FNGR & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FNGR
- FBRX
- Stock Information
- Founded
- FNGR 2016
- FBRX N/A
- Country
- FNGR Singapore
- FBRX United States
- Employees
- FNGR N/A
- FBRX N/A
- Industry
- FNGR Computer Software: Prepackaged Software
- FBRX Biotechnology: Pharmaceutical Preparations
- Sector
- FNGR Technology
- FBRX Health Care
- Exchange
- FNGR Nasdaq
- FBRX Nasdaq
- Market Cap
- FNGR 72.0M
- FBRX 59.5M
- IPO Year
- FNGR N/A
- FBRX N/A
- Fundamental
- Price
- FNGR $1.26
- FBRX $5.71
- Analyst Decision
- FNGR
- FBRX Strong Buy
- Analyst Count
- FNGR 0
- FBRX 4
- Target Price
- FNGR N/A
- FBRX $77.58
- AVG Volume (30 Days)
- FNGR 275.9K
- FBRX 19.0K
- Earning Date
- FNGR 01-14-2025
- FBRX 03-17-2025
- Dividend Yield
- FNGR N/A
- FBRX N/A
- EPS Growth
- FNGR N/A
- FBRX N/A
- EPS
- FNGR N/A
- FBRX N/A
- Revenue
- FNGR $33,570,107.00
- FBRX N/A
- Revenue This Year
- FNGR $260.03
- FBRX N/A
- Revenue Next Year
- FNGR N/A
- FBRX N/A
- P/E Ratio
- FNGR N/A
- FBRX N/A
- Revenue Growth
- FNGR N/A
- FBRX N/A
- 52 Week Low
- FNGR $1.03
- FBRX $4.11
- 52 Week High
- FNGR $3.96
- FBRX $28.68
- Technical
- Relative Strength Index (RSI)
- FNGR 49.54
- FBRX 21.19
- Support Level
- FNGR $1.12
- FBRX $6.51
- Resistance Level
- FNGR $1.43
- FBRX $9.90
- Average True Range (ATR)
- FNGR 0.13
- FBRX 0.95
- MACD
- FNGR 0.01
- FBRX -0.15
- Stochastic Oscillator
- FNGR 40.29
- FBRX 0.00
About FNGR FingerMotion Inc.
FingerMotion Inc is engaged in the provision of mobile payment and recharge services in the Chinese market. The company business line includes Telecommunications Products and Services; Value Added Products and Services; Short Message Services (SMS) and Multimedia Messaging Services (MMS); a Rich Communication Services (RCS) platform; Big Data Insights; and a Video Games Division (inactive). It principally earns revenue by providing mobile payment and recharge services to customers of telecommunications companies in China.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA).